July 7, 2020 Minutes from Extraordinary General Meeting in Vaccibody AS

Posted at 08:00h in Uncategorized

Minutes from Extraordinary General Meeting in Vaccibody AS...

Read More

July 2, 2020 Vaccibody doses first patient in Phase II clinical trial of VB10.16 in combination with immune-checkpoint inhibitor in advanced cervical cancer

Posted at 07:57h in Uncategorized

Vaccibody doses first patient in VB C-02 tudy with VB10.16 plus atezolizumab (PDF)....

Read More

June 29, 2020 NOTICE OF AN EXTRAORDINARY GENERAL MEETING 6 JULY 2020

Posted at 12:00h in Uncategorized

NOTICE OF AN EXTRAORDINARY GENERAL MEETING 6 JULY 2020 (PDF)...

Read More

May 12, 2020 QUARTERLY REPORT – 2020 Q1

Posted at 08:00h in quarterly-reports

QUARTERLY REPORT – 2020 Q1 (PDF)...

Read More

April 23, 2020 Minutes from Annual General Meeting in Vaccibody AS

Posted at 14:04h in Uncategorized

Minutes from Annual General Meeting in Vaccibody AS...

Read More

April 15, 2020 2019 Annual Report and Notice of Annual General Meeting April 22nd, 2020

Posted at 08:00h in Uncategorized

Invite Notice Report...

Read More

April 14, 2020 Invitation to Business Update April 16th 2020

Posted at 09:24h in Uncategorized

Invitation to Business Update April 16th 2020...

Read More

April 1, 2020 Vaccibody AS initiates research in infectious diseases and hires Gunnstein Norheim, former Vaccine Science Director at CEPI, to lead initiative

Posted at 07:45h in Uncategorized

Vaccibody AS initiates research in infectious diseases and hires Gunnstein Norheim, former Vaccine Science Director at CEPI, to lead initiative...

Read More

March 24, 2020 FINANCIAL CALENDAR 2020

Posted at 11:06h in Uncategorized

Financial calendar 2020...

Read More

January 27, 2020 VACCIBODY REGISTRATION AND TRADING ON NOTC

Posted at 00:40h in quarterly-reports

Vaccibody AS will be registered on the NOTC-list as of January 27, 2020...

Read More